Dare Bioscience (DARE) Stock Price, Quote, News & History | Benzinga

Dare Bioscience Inc (DARE) Stock Price, Quote, News & History

DARENASDAQ

Trade with Public

Trade with Public

$2.01

-0.0696-3.35%

Last update: Jun 18, 9:24 AM

OverviewNews Earnings Events Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$2.08

Close

-

Volume / Avg.

65.02K / 609.68K

Day Range

$2.05 - $2.17

52 Wk Range

1.27 - 9.19

Market Cap

$30.11M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

5.54%

Days to Cover

2.56

Recent Dare Bioscience Inc News

Why Is Nano-Cap Dare Bioscience Stock Trading Higher On Tuesday?

Dare Bioscience stock climbed after Phase 3 interim data for Ovaprene showed expected pregnancy rates and no trial changes by DSMB.

Vandana Singh

Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Avi Kapoor

Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval

Bayer to present detailed Phase 3 OASIS 1 and 2 study results showing elinzanetant significantly reduces moderate to severe menopausal vasomotor symptoms compared to placebo.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-9.94M

Investing Cash Flow (TTM)

-227.95K

Financing Cash Flow (TTM)

18.32M

Free Cash Flow (TTM)

-10.16M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

8.15M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$14.25M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

22.68

PB Ratio (TTM)

42.46

Earnings Yield % (TTM)

-43.75%

Earnings Yield % (FWD)

-43.27%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.05

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$2.71M

Total Cash

$18.52M

Debt to Equity

2.20

Issuance of Debt (TTM)

-$2.22M

Repayment of Debt (TTM)

-$2.71M

Key Statistics

Open

$2.08

Close

-

Volume / Avg.

65.02K / 609.68K

Day Range

$2.05 - $2.17

52 Wk Range

1.27 - 9.19

Market Cap

$30.11M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

48

Short Interest

5.54%

Days to Cover

2.56

About

Sector

Health Care

Industry

Pharmaceuticals

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-bein...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Dare Bioscience (DARE) stock?

A

You can purchase shares of Dare Bioscience (NASDAQ:DARE) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Dare Bioscience (DARE) competitors?

A

There are no as such competitors for Dare Bioscience.

Q

What is the forecast, or price target, for Dare Bioscience (DARE) stock?

A

Dare Bioscience has a consensus price target of $9.00.

Q

What is the current price for Dare Bioscience (DARE)?

A

The stock price for Dare Bioscience (NASDAQ: DARE) is $2.0104 last updated June 18, 2026 at 9:24 AM EDT.

Q

Does Dare Bioscience (DARE) pay a dividend?

A

There are no upcoming dividends for Dare Bioscience.

Q

When is Dare Bioscience (NASDAQ:DARE) reporting earnings?

A

Dare Bioscience does not have any upcoming earnings scheduled.

Q

Is Dare Bioscience (DARE) going to split?

A

There is no upcoming split for Dare Bioscience.

Q

What sector and industry does Dare Bioscience (DARE) operate in?

A

Dare Bioscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.